IBSA: Advancing Topical Patch Technology

As a leading multinational pharmaceutical company, IBSA USA’s parent company, IBSA Group continues to advance the science of drug formulation and delivery with one goal in mind: improving patient outcomes. IBSA’s unique transdermal and topical patch technology exemplifies this commitment. The focal point of IBSA operations is to take existing therapeutic solutions and make them even better. In the United States, IBSA USA markets prescription topical patches. These products are designed to release the active ingredient in a controlled manner over a defined period.

A Leader in Transdermal and Topical Delivery

Backed by decades of expertise, IBSA Group has become one of the few pharmaceutical manufacturers globally with the ability to develop and produce both single- and multilayer medicated patches for local or systemic delivery. These patches utilize patent-protected, proprietary Hydrogel and Drug-in-Adhesive technologies — developed through IBSA’s continuous research and development efforts.
The structure of IBSA’s patches typically includes:

• An adhesive matrix (made of polyacrylate, silicone, or other materials) containing the active substance
• A support layer to ensure flexibility and comfort
• A protective liner that is removed before application

IBSA’s specialized manufacturing processes ensure consistent drug distribution across the patch surface, supporting predictable and sustained drug release profiles. This level of quality control reflects IBSA’s broader commitment to pharmaceutical excellence across all areas of formulation and production.
 

Topical Patch Technology

Patches for topical use are designed to provide several advantages, including:
•    Maintenance of steady and optimal drug concentrations over time
•    Reduced dosing frequency, supporting patient adherence
•    May be better tolerated by some patients 
•    May lower systemic exposure 

Commitment to Patient-Centered Innovation

Through ongoing investment in research, manufacturing, and drug delivery technology, IBSA remains at the forefront of topical patch development. Its expertise and global production capacity continue to drive innovation in this important area of pharmaceutical care. 

PM-1243-v1